← Back to Search

Behavioral Intervention

TEMPO for Prostate Cancer

N/A
Waitlist Available
Led By Sylvie Lambert, PhD
Research Sponsored by St. Mary's Research Center, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 weeks post-baseline and 24 weeks post-baseline
Awards & highlights

Study Summary

"This trial focuses on helping men with prostate cancer and their caregivers cope with the physical and emotional challenges that come with the disease and its treatment. The research team developed a program called TEMPO, which is

Who is the study for?
This trial is for men with prostate cancer and their caregivers. It's designed to help them manage the emotional and physical challenges of cancer without needing a healthcare professional. Participants will use TEMPO, a web-based program offering coping skills training and exercise routines.Check my eligibility
What is being tested?
TEMPO, a self-management program for prostate cancer patients and their caregivers, is being tested against simply monitoring anxiety levels over 12 weeks. The study aims to see if TEMPO improves health outcomes without professional guidance.See study design
What are the potential side effects?
Since TEMPO is a non-medical intervention focusing on psychosocial support and physical activity, it may not have typical medical side effects but could include increased stress or discomfort from new exercises.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 weeks post-baseline and 24 weeks post-baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks post-baseline and 24 weeks post-baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HADS-Anxiety
Secondary outcome measures
TEMPO's key mechanisms of action

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TEMPOExperimental Treatment1 Intervention
Using a stepped care approach, TEMPO will be provided across two intervention stages with variations on timing (initial vs. delayed) and intensity (self-directed vs. guided). All dyads will continue to access usual care (a co-intervention measure is included).
Group II: Actively Monitoring dyads' anxietyActive Control1 Intervention
Patients will receive usual care throughout the study. Dyads in this group will not receive any information resources from the research team but will have access to all of those available at their participating center (sites will be asked to provide a description of usual care practices). Dyads not responding to active monitoring will be stepped up to TEMPO; responders to active monitoring will only be invited to complete the follow-up measures.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TEMPO
2020
N/A
~90

Find a Location

Who is running the clinical trial?

Université de MontréalOTHER
214 Previous Clinical Trials
102,395 Total Patients Enrolled
1 Trials studying Prostate Cancer
30 Patients Enrolled for Prostate Cancer
Memorial University of NewfoundlandOTHER
68 Previous Clinical Trials
1,831,646 Total Patients Enrolled
2 Trials studying Prostate Cancer
1,530 Patients Enrolled for Prostate Cancer
St. Mary's Research Center, CanadaLead Sponsor
8 Previous Clinical Trials
1,329 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots for patients to participate in this research study?

"According to clinicaltrials.gov, this particular medical trial is no longer enrolling participants. The listing was first published on September 1st, 2024 and last revised on April 9th, 2024. Despite its closure, there are currently a total of 1831 other active trials available for patient enrollment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
Sylvie Lambert 2024. "A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06363266.
~251 spots leftby Aug 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top